The Boston Globe

Business

Bioartificial organs may ease need for donors

Trachea transplant presages a new era

Christopher Lyles flew home to Baltimore last week, two months after becoming the second patient ever to receive an artificial trachea, made of a plastic scaffold seeded with his own cells. The need for artificial tracheas is small but researchers hope to be able to use the same basic technique to manufacture other “bioartificial’’ organs. Harvard Bioscience Inc., the Holliston-based company that made Lyles’ new trachea, anticipates that the bioartificial-organ transplant industry will eventually top $1 billion a year.

Thank you for reading BostonGlobe.com. You have reached the monthly limit for free articles — to continue reading, get unlimited access to BostonGlobe.com now for just 99¢ for 8 weeks.

Unlimited access to BostonGlobe.com includes:

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
GET STARTED TODAY

BostonGlobe.comSubscriber Log In

Contact us for help